Martine has over 25 years of combined R&D and global regulatory strategy experience. Since joining Alexion in 2009, she has been dedicated to the registration of several orphan medicinal products across the globe, as well as to the shaping of the regulatory environment for medicines under development for rare diseases. Prior to Alexion, Martine held R&D and regulatory roles in companies including Aventis (now Sanofi), Servier, and H. Lundbeck A/S.
Martine received her PharmD from the University Louis Pasteur in Strasbourg, France, and serves as a Director on the Board of Inventiva Pharma. She is a champion of diversity, equality, inclusion, and belonging, recognized by the Healthcare Businesswoman’s Association as a Luminary in 2020.